The Global Urodynamic Devices Market Is Likely To Reach A Valuation Of US$ 150 Mn By The End Of 2022

Urodynamic study enables physicians in diagnosing causes, and identifying their nature, or detecting dysfunctions in the lower urinary tract. The primary objective of an urodynamic test is understanding disorders/problems occurring in lower urinary tract by duplication of symptoms. Urodynamic study also help in determination of the causes of bladder dysfunction, formulating an appropriate course for the treatment. According to the World Health Organization (WHO), 330,000 cases of bladder cancer have been diagnosed annually across the globe. In addition, the National Association of Incontinence has estimated 200 Mn people to be affected with urinary incontinence worldwide every year.

These incidences have propelled demand for urodynamic devices, owing to rising clinical urgency. A number of healthcare initiatives are being taken for creating awareness about urological problems, along with the availability of treatment and diagnostics for urological disorders.

For example, the initiative in Japan – “Let’s Talk and Think About Continence”, and the “Continence Awareness Week” conducted by Continence Foundation in the U.K. These initiatives have deprived people of the social stigma related to these problems, encouraging them to start consulting physicians, which in turn has been augmenting growth of the global urodynamic devices market. Moreover, a slew of technological advancements are being observed in urodynamic devices such as penile cuff, intravesical prostatic protrusion, condom catheter, and ultrasound video urodynamic.

Get Sample Copy With Impact Analysis Of COVID-19 Of Market Report –https://www.factmr.com/connectus/sample?flag=S&rep_id=168

Increasing Initiatives to Spread Awareness about Urological Disorders to Boost the Market Growth

The World Health Organization (WHO) has estimated over 300,000 patients to be affected with bladder cancer annually around the world. The National Association of Incontinence estimates roughly 200 Mn population across the globe to be suffering from urinary incontinence every year. Incidences such as these have increased demand for urodynamic devices, along with the rise in clinical urgency. Numerous healthcare initiatives have been creating awareness about urological disorders, coupled with availability of diagnostics and treatment for urological problems. Some initiatives among these include “Continence Awareness Week” undertaken by the U.K.’s Continence Foundation, and Japan’s “Let’s Talk and Think About Continence”. These initiatives are depriving people of social stigma, encouraging them to consult physicians. The aforementioned factors will boost growth of the global urodynamic devices market in the upcoming years.

Uroflowmetry Urodynamic Devices to Remain Sought-after in the Market

Uroflowmetry urodynamic devices will continue to be sought-after among physicians, and revenues from sales of uroflowmetry urodynamic devices will hold more than one-fourth share on global revenues throughout the forecast period. Significant use of uroflowmetry to diagnose prostate cancer, benign prostatic hypertrophy, urinary blockage, bladder cancer, neurogenic bladder, and bladder dysfunction, are contributing to demand for uroflowmetry urodynamic devices in hospitals and urology clinics globally. In addition, sales of urodynamic catheters are projected to register the fastest expansion in the market through 2022.

Urology clinics will continue to be the fastest growing end-users of urodynamic devices in the global market. Hospitals are estimated to remain the largest end-users of urodynamic devices over the forecast period. North America will account for the largest share of the revenues from urodynamic devices sales in hospitals. Urodynamic devices sales in hospitals are anticipated to account for more than US$ 150 Mn revenues by 2022-end.

Speak To Research Analyst For Detailed Insights: https://www.factmr.com/connectus/sample?flag=AE&rep_id=168

Competition Tracking

Key players participating in the global urodynamic devices market include

  • Albyn Medical Ltd.
  • Boston Scientific Corporation
  • Medica SpA
  • Neomedix Systems Pty. Ltd.
  • Dantec Dynamics A/S
  • CooperSurgical Inc.
  • LABORIE
  • Verathon Inc.
  • Best Medical International Inc.

Market Taxonomy

Device Type   

  • Uroflowmetry
  • Ambulatory Urodynamic Devices
  • Cystometer
  • Video Urodynamic Devices
  • Electromyography
  • Urodynamic Catheters
  • Urodynamic Pumps And Transducer Sets

End User        

  • Hospitals
  • ASCs
  • Urology Clinics
  • Others

Interested to Procure The Data? Inquire here at –https://www.factmr.com/checkout/168

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Email: [email protected]
Visit Our Website: https://www.factmr.com